In the past several months, the NIH has been dealing with various scientists who have not disclosed payments to them by outside companies for doing research. The ethical rules guiding whether researchers had to disclose money they made from outside research were rather obtuse. Last September, Dr. Elias Zerhouni, the director of the NIH, imposed a one-year moratorium on receiving an honoria by NIH scientists for any outside research, because the NIH has to conduct an across-the-board investigation into the scope of the problem. Recently, the NIH opened an investigation into a particular researcher who allegedly received over $500,000 from Pfizer for collaboration in doing research regarding Alzheimer's disease as well as for representing Pfizer at certain conferences.
The researcher's defense seems weak at best.